Loading
Latest filing published 17 Aug 2022 for Turning Point Therapeutics, Inc., €3.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Brian Sun on record concern Turning Point Therapeutics, Inc. The record holds 2 filings, for trades running from 11 April 2022 to 17 August 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 17 August 2022: a transaction of €3.4M, in Turning Point Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.